Olivia Newton-John Cancer Wellness & Research Centre

Heidelberg (Australia au)
Oncology
Clinical endpoint Radiotherapy Tumor Microenvironment Tolerability Prostate Cancer Tumor Regression Biomarkers for Immunotherapy Metastatic Prostate Cancer Cancer Cancer Immunoediting
Watch Introduction

Bibliometric indicators

Evolution over the last years of activity

Showing the period - Sept. 2024

2,027
Activity
3%

Total documents

2.7
Impact
3%

Normalized Impact

432
Excellence
3%

Highly Cited Papers (Top 10%)

62.8
Leadership
3%

Leadership (%)

47.4
Mobility & Collaboration
3%

International Collaboration (%)

72
Excellence
3%

Outstanding papers (Top 1%)

13.9
Leadership
3%

Women Leading (%)

4.8
Leadership
3%

Women Leading International (%)

66.4
Open Access
3%

Open Access (%)

Main Research Fields (top 9 by publications)

Indicators:

Net Change
3%

Net Change
3%

Net Change
3%

Net Change
3%

Net Change
3%

Net Change
3%

Net Change
3%

Net Change
3%

Net Change
3%

Human Resources

Historical perspective

From to Sept. 2024

Current resources

Quick filters

Career Stage
Occasional Junior Researcher Senior Leading
Performance
Standard Good Excellent Outstanding
Gender
Male Female
Reset
0

Personnel

0.0

Papers / Personnel

0

Leading women (%)

0
0

Gender (%)

0

Papers / Permanent researchers

0

Papers / Leading researchers

Career stage

Performance

Years of Activity

ONE Index (distribution)

ONE Index by Main Research Fields

ONE Index vs. Years of Activity

Main authors

ID Name Gender Discipline Career Stage ONE Index Years Activity NDocs RCI HCP Leader Collab.
1 Cebon, Jonathan male Immunology, Oncology, Molecular Biology Leading researcher 910 40 429 4.73 108 31.0% 43.1%
2 Scott, Andrew male Radiology, Nuclear Medicine and Imaging Leading researcher 888 131 1,067 1.93 197 54.9% 26.0%
3 Behren, Andreas male Molecular Biology, Oncology Senior researcher 886 20 147 7.76 53 18.4% 46.3%
4 Weickhardt, Andrew male Pulmonary and Respiratory Medicine, Oncology Senior researcher 862 17 156 4.58 35 26.3% 44.2%
5 Yang male Molecular Biology Senior researcher 845 18 112 13.19 34 24.1% 33.0%
6 Gan, Hui female Oncology Leading researcher 831 60 467 2.00 70 25.9% 42.4%
7 Mielke, Lisa female Immunology Researcher 831 21 72 3.75 30 30.6% 44.4%
8 Fahandej, Maziar male Otorhinolaryngology, Speech and Hearing Occasional author 801 8 6 0.87 0 0.0% 83.3%
9 Ernst, Matthias male Oncology, Molecular Biology Leading researcher 799 98 363 2.12 89 31.1% 32.8%
10 Mariadason, John male Molecular Biology Leading researcher 797 49 234 1.90 51 32.9% 38.9%
11 Foroudi, Farshad male Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging Leading researcher 796 30 275 1.46 35 43.6% 25.1%
12 Hawkes, Eliza female Pathology and Forensic Medicine Leading researcher 788 44 232 1.23 31 39.7% 42.2%
13 Christine D. Dijkstra Immunology Leading researcher 788 66 245 2.63 61 39.6% 25.7%
14 Pal, Bhupinder male Oncology, Molecular Biology Senior researcher 775 18 86 4.76 28 11.6% 37.2%
15 O'Brien, Megan female Law Leading researcher 772 50 182 0.63 14 75.3% 7.1%
16 Wilson, Carlene female Oncology Leading researcher 764 97 392 1.41 65 48.0% 12.2%
17 Thapa, Bibhusal male Pulmonary and Respiratory Medicine Senior researcher 698 15 54 1.23 7 33.3% 27.8%
18 Arulananda, Surein female Pulmonary and Respiratory Medicine Researcher 684 14 42 1.60 9 59.5% 26.2%
19 Ostrouska, Simone male Immunology Researcher 681 7 18 1.97 4 0.0% 55.6%
20 Huynh, Jennifer female Oncology Senior researcher 677 19 69 1.32 13 39.1% 27.5%
21 Skaczkowski, Gemma female Public Health, Environmental and Occupational Health Researcher 666 13 46 1.30 10 52.2% 6.5%
22 Do, Hongdo female Molecular Biology Senior researcher 665 18 65 2.43 16 26.2% 15.4%
23 Jenkins, Laura female Molecular Biology Researcher 645 8 30 0.92 5 26.7% 20.0%
24 Mooi, Jennifer female Oncology Researcher 629 14 36 2.56 9 41.7% 27.8%
25 Eissmann, Moritz male Molecular Biology, Immunology, Oncology Senior researcher 626 19 47 2.77 9 38.3% 48.9%
910
One Index
 Cebon, Jonathan PhD   0000-0002-3898-950X 429 docs (1985 - 2024)  
Melanoma , Antigen Presentation , Dabrafenib , Cancer Genomics , Trametinib
888
One Index
 Scott, Andrew PhD   0000-0002-6656-295X 1067 docs (1894 - 2024)  
Biodistribution , PET/CT , Cancer Treatment , Cancer Imaging , Imaging
886
One Index
 Behren, Andreas PhD   0000-0001-5329-280X 147 docs (2005 - 2024)  
Melanoma , Cancer Genomics , Table (database) , Tumor Evolution , Intratumor Heterogeneity
862
One Index
 Weickhardt, Andrew PhD   0000-0002-6482-9681 156 docs (2008 - 2024)  
Regorafenib , Metastatic Prostate Cancer , Clinical endpoint , Treatment , Cabazitaxel
845
One Index
 Yang PhD   0000-0002-9746-2839 112 docs (2007 - 2024)  
IRF4 , Cancer Therapy , ErbB , Memory T Cells , sequence alignment
831
One Index
 Gan, Hui PhD   0000-0001-7319-8546 467 docs (1965 - 2024)  
Glioblastoma , Temozolomide , Regimen , Tolerability , Biodistribution
831
One Index
 Mielke, Lisa PhD   0000-0002-9522-9320 72 docs (2004 - 2024)  
Innate lymphoid cell , cytokine signaling , Innate Lymphoid Cells , Granulation , Regulatory T Cells
801
One Index
 Fahandej, Maziar 6 docs (2017 - 2020)  
Feeding tube , Radiotherapy , Cancer Therapy , Univariate analysis , Nutritional Support
799
One Index
 Ernst, Matthias PhD   0000-0002-6399-1177 363 docs (1927 - 2024)  
Glycoprotein 130 , Cancer , cytokine signaling , Tumor Microenvironment , Regorafenib
797
One Index
 Mariadason, John PhD   0000-0001-9123-7684 234 docs (1976 - 2024)  
Metastatic Colorectal Cancer , Molecular Characterization , Regorafenib , HDAC Inhibitors , BRAF Mutations
796
One Index
 Foroudi, Farshad PhD   0000-0001-8387-0965 275 docs (1995 - 2024)  
Radiotherapy , Image-Guided Radiotherapy , Intensity-Modulated Radiotherapy , Radiotherapy Physics , Fiducial marker
788
One Index
 Hawkes, Eliza PhD   0000-0002-0376-2559 232 docs (1981 - 2024)  
Mantle Cell Lymphoma , Follicular lymphoma , Refractory (planetary science) , International Prognostic Index , Clinical endpoint
788
One Index
 Christine D. Dijkstra PhD 245 docs (1959 - 2024)  
Encephalomyelitis , Monocyte , Follicular dendritic cells , Neuroinflammation , Dendritic Cells
775
One Index
 Pal, Bhupinder PhD   0000-0002-3684-4331 86 docs (2007 - 2024)  
Venetoclax , Breast Cancer , Metastatic Breast Cancer , Cell Heterogeneity , Stem Cell Niches
772
One Index
 O'Brien, Megan PhD   0000-0002-9687-919X 182 docs (1975 - 2023)  
Judicial Instructions , Jury instructions , Welfare Rights Advice , Juror Comprehension , Hung jury
764
One Index
 Wilson, Carlene PhD   0000-0002-1883-4690 392 docs (1928 - 2024)  
Screening , Breast Cancer Screening , Consumption (sociology) , Patient Participation , Diet Quality
698
One Index
 Thapa, Bibhusal PhD   0000-0003-0978-6671 54 docs (2010 - 2023)  
Malignant Pleural Mesothelioma , Tissue microarray , Tumor Microenvironment , Tumor-infiltrating lymphocytes , Biomarkers for Immunotherapy
684
One Index
 Arulananda, Surein PhD   0000-0002-5636-6381 42 docs (2011 - 2024)  
EGFR Mutations , Malignant Pleural Mesothelioma , T790M , Osimertinib , Pemetrexed
681
One Index
 Ostrouska, Simone PhD   0000-0001-7582-3990 18 docs (2018 - 2024)  
Table (database) , Super-Enhancers , Antigen Presentation , Tumor Immunity , Memory T Cells
677
One Index
 Huynh, Jennifer PhD   0000-0002-2638-8352 69 docs (2006 - 2024)  
Gestational Diabetes Mellitus , Tumor Microenvironment , Taste Receptors , Type 2 Diabetes , Cardiac Imaging
666
One Index
 Skaczkowski, Gemma PhD   0000-0003-0715-3563 46 docs (2012 - 2024)  
Adolescent and Young Adult Oncology , Childhood Cancer Survivor Study , Thematic analysis , Cancer Survivorship , Internet-based Interventions
665
One Index
 Do, Hongdo PhD   0000-0003-0425-4406 65 docs (2007 - 2021)  
High Resolution Melt , Cancer Genomics , EGFR Mutations , Amplicon , Massive parallel sequencing
645
One Index
 Jenkins, Laura PhD   0000-0001-9218-8669 30 docs (2017 - 2024)  
Regorafenib , Therapeutic Targets , HDAC Inhibitors , Trametinib , Cancer
629
One Index
 Mooi, Jennifer PhD   0000-0002-4188-6149 36 docs (2011 - 2024)  
Metastatic Colorectal Cancer , Clinical endpoint , Metastatic Cancer , Microtubule-Targeting Agents , Progression-free survival
626
One Index
 Eissmann, Moritz PhD   0000-0002-2855-0616 47 docs (2006 - 2024)  
Cancer , MALAT1 , Tumor Microenvironment , Cancer Progression , Gene Expression Regulation